Skip to main content
SpringerLink
Log in

Physical/Chemical Description

  • Chapter
Safety and efficacy of radiopharmaceuticals

Part of the book series: Developments in Nuclear Medicine ((DNUM,volume 4))

  • 94 Accesses

Abstract

The purpose of this paper is to review the methods having been used for description of the safety and efficacy of a radiopharmaceutical (RPh). Since the group named “radiopharmaceuticals” is quite inhomogeneous in the chemical and physical properties of its individuals it is useful to explain why and when the particular methods are being used, i.e. to explain the methodical approach.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. WHO Expert Committee on Specifications for Pharmaceutical Preparations, 25th Report Techn Rep Ser 567, Geneva;: WHO, 1975:62.

    Google Scholar 

  2. Penkoske P, Potchen EJ, Welch MJ, Welch TJ. Clinical chemistry of the tin-indium generator. J Nucl Ned 1969; 10: 646–650.

    CAS  Google Scholar 

  3. Tubis M, Nordyke RA, Posnick E, Bladh WH. The preparation and use of 1–131 labelled sulfobromophthalein in liver function testing. J Nucl Med 1961; 2: 282–288.

    PubMed  CAS  Google Scholar 

  4. Mani RS, Prabhu TP. Trace labelling of bromsu1pha1ein/BSP/with radioiodine. Isotopenpraxis 1969; 5: 277–282.

    Article  CAS  Google Scholar 

  5. Suarez AF de, Gomez SO, Mitta AEA. Rapid method for preparation of iodine-131 labelled bromsu1fa1ein. Radiochim Acta 1969; 12: 172.

    Google Scholar 

  6. Iya VK, Mani RS, Desai CN. Preparation of labelled molecules. In: Radioisitope Production and Quality control, IAEA Techn Rep Ser 125, Vienna, I.A.E.A., 1971; 823–860.

    Google Scholar 

  7. Kato S, Kurata K. Radioactive mono and diiodo sulfobromphthalein. US Patent No 3,743,713; June 22, 1971.

    Google Scholar 

  8. Kato S, Kurata K, Wakebeyashi T. Structure of iodine-131-labelled 3,3,-/tetrabromophthalidylidene/bis/6-hydroxyben-zene sulfonic acid. Chem Pharm Bull 1972; 20: 581–583.

    CAS  Google Scholar 

  9. Saguansri P, Songkhla SN, Suwanik R, Plechachinda R, Intarusput C. Simplified method of preparation of iodine-131 labelled BSP/bromsulphalein/ and identification of its major component as iodine-131–1abe11ed BSP monoiodide. Siriraj Hosp Gaz 1973; 25: 1877–1889, Chem Abstr 81: 10681j

    CAS  Google Scholar 

  10. Angelis B, Cifka J. Quality control of bromsu1pha1ein-I-131 injections. 2nd CMEA Symposium on Radiopharmaceuticals, Poland, Kazimierz Dolny, 1977, 7 pp

    Google Scholar 

  11. Cifkova I, Cifka J. Biological behaviour of individual fractions of 1–131 labelled bromsulphalein. 2nd CMEA Symposium on Radiopharmaceuticals, Poland, Kazimierz Dolny, 1977, 6 pp

    Google Scholar 

  12. Eckelman WC, Reba RC, Kubota H. Tc-99m Pyrophosphate for bone imaging. J Nucl Med 1974; 15: 279–283.

    PubMed  CAS  Google Scholar 

  13. Brand JAGM van den, Dekker GB, Ligny CI de. A comparative investigation of various Sephadex G-types and Biogel P-10 in the gel chromatographic analysis of Tc-99m labelled ethane-1-hydroxy-1, 1-disodium diphosphonate. Int J Appl Radiation Isotopes 1979; 30: 129.

    Article  Google Scholar 

  14. Darte L. A Comparative investigation of the gel chromatography column scanning method for quality control of Tc-99m-methylenediphosphonate. Nucl Med 1981; 20: 51–63.

    CAS  Google Scholar 

  15. Gallium citrate (Ga-67) injection. The Pharmacopoeia of the United States of America, XXth Rev., Addendum a to Supplement I, 1980: 127.

    Google Scholar 

  16. Kopecky P, Polackova E, Cifka J et al. Progress report on gallium-67 preparation. Nucl Res Inst Rez, Report U3V 5546 1980: 36 pp.

    Google Scholar 

  17. Hnatowich DJ, Kulprathipanja S, Beh B. The effect of preparation quality on biodistribution for Ga-67 citrate. J Label1 Comp Radiopharm 1977; 13: 180.

    CAS  Google Scholar 

  18. Vallabhajosula SR, Harwig JF, Siemsen JK, Wolf W. Behavior of gallium-67 in the blood. The role of transferrin. J Labeil Comp Radiopharm 1979; 16: 112–114.

    CAS  Google Scholar 

  19. Steigman J, Meinken G, Richards P. The reduction of pertechnetate-99 by stannous chloride 1. The stoichiometry of the reaction in HCl, in a citrate buffer and in a DTPA buffer. Int J Appl Radiat Isotopes 1975; 26: 601–609.

    Article  CAS  Google Scholar 

  20. Eckelman WC, Meinken G, Richards P. The chemical state of Tc-99m in biomedical products. 2, The Chelation of reduced technetium with DTPA. J Nucl Med 1972; 13: 577–581.

    PubMed  CAS  Google Scholar 

  21. Billinghurst MW, Rempel S, Williams S. Reduction Requirements of technetium-99m pertechnetate for the formation of technetium radiopharmaceuticals. J Labell Comp Radiopharm 1979; 16: 185–187.

    CAS  Google Scholar 

  22. Brand JAGM van den, Dekker BG, DAS HA, Ligny CL de. Gel chromatographic separation and identification of Tc/Sn/EHDP complexes using the radiotracers P-32, Tc-99m, and Sn-113. Int J Appl Radiat Isotopes 1981; 32: 637.

    Article  Google Scholar 

  23. Johannsen B, Syhre R, Spies H, Mûnze R. Chemical and biological characterization of different Tc complexes of cysteine and cysteine detivatives. J Nucl Med 1978; 19: 816–24.

    PubMed  CAS  Google Scholar 

  24. Johannsen B, Spies H. Chemie und Radiopharmakologie von Technetiumkomplexen. ZfK Rossendorf Bericht 1981; 213 pp

    Google Scholar 

  25. Marzilli LG, Worley P, Burns HD. A new electrophoretic method for determining ligand: technetium stoichiometry in carrier free Tc-99m radiopharmaceuticals. J Nucl Med 1979; 20: 871–876.

    PubMed  CAS  Google Scholar 

  26. Russell CD, Crittenden RC, Cash Ag. Determination of net ionic charge on Tc-99m DTPA and Tc-99m EDTA by a column ion-exchange method. J Nucl Med 1980; 21: 354–360.

    PubMed  CAS  Google Scholar 

  27. Kievet W de. Technetium radiopharmaceuticals: chemical characterization and tissue distribution of Tc-gluco-heptonate using Tc-99m and carrier Tc-99. J Nucl Med 1981; 22: 703–9.

    Google Scholar 

  28. Mulder G, Oldenburg SO, Oort WJ van, Hartigh J den. Valence state of technetium in technetium methylene diphosphonate at tracer concentrations, measured by amperometry. Int J Appl Radiat Isotopes 1981; 32: 675–677.

    Article  CAS  Google Scholar 

  29. Vanlic-Razumenic N, Petrovic J. Preparation of technetium-99-DMS renal complex in solution and its chemical and biological characterization. Int J Appl Radiat Isotopes 1982; 33: 277–284.

    Article  CAS  Google Scholar 

  30. Johannsen B. Reaction of Tc-99m diphosphonate with N-donor ligands. Int J Appl Radiat Isotopes 1982; 33: 429–432.

    Article  CAS  Google Scholar 

  31. Garcia R, Galvez J, Moreno JL. Stoichiometric and kinetic study of the Tc-99 DMSA complex obtained with stannous excess: a possible model for the physico-chemical behaviour of the radiopharmaceutical Tc-99m DMSA. Int J Appl Radiat Isotopes 1982; 33: 521–524.

    Article  CAS  Google Scholar 

  32. Johannsen B, Syhre R. Untersuchungen zur Komplexierung von Tc-99 mit Gluconat. Radiochem Radioanal Letters 1978; 36: 107–110.

    CAS  Google Scholar 

  33. Russel CD, Cash AG. Oxidation state of technetium in bone scanning agents as determined at carrier concentration by amperometric titration. Int J Appl Radiat Isotopes 1979; 30: 485–488.

    Article  Google Scholar 

  34. Burns HD, Sowa DT, Worley P, Vaum R, Marzilli LG. Electrophoretic determination of charge on carrier-free Tc-99m labelled complexes. J Pharm Sci 1981; 70: 436–439.

    Article  PubMed  CAS  Google Scholar 

  35. Jones AG, Davison A, La Tegola MR et al. Chemical and in vivo studies of the anion oxo /N, N,-ethylenbis/2-mercap-toacetimido//technetate/V/. J Nucl Med 1982;23: 801–809.

    PubMed  CAS  Google Scholar 

  36. Loberg MD, Cooper M, Harvey E, Callery P, Faith W. Development of new radiopharmaceuticals based on N-substitition of imidodiacetic acid. J Nucl Med 1976; 17: 633–638.

    PubMed  CAS  Google Scholar 

  37. Callery PS, Faith WC, Loberg MD, Fields AT, Harvey EB, Cooper MD. Tissue distribution of technetium-99m and carbon-14 labelled N-/2, 6-dimethylphenylcarbamoylmethyl /iminodiacetic acid. J Med Chem 1976; 19: 962–964.

    Article  PubMed  CAS  Google Scholar 

  38. Ryan J, Cooper M, Loberg M Harvey E, Sikorski S. Technet ium-99m-labelled N-/2, 6-dimethylpheny lcarbanoyl-methyl/iminodiacetic acid /Tc-99m HIDA/: A new radiopharmaceutical for hepatobiliary imaging studies. J Nucl Med 1977; 18: 997–1004.

    PubMed  CAS  Google Scholar 

  39. Loberg MD, Fields At. Chemical structure of technetium-99m-labelled N-/2, 6-dimethylphenylcarbamoylmethyl/iminodiacetic acid /Tc-HIDA/. Int J Appl Radiat Isotopes 1978; 29: 167–173.

    Article  CAS  Google Scholar 

  40. Davison A, Jones A, Orvig C, et al. A new class of oxotechnetium/+5/ chelate complexes containing a TcON2S2core. Inorg Chem 1981; 20: 1629–1632.

    Article  CAS  Google Scholar 

  41. Fritzberg AR, Klingensmith WC, Whitney WP, et al. Chemical and biological studies of Tc-99m N, N, bis/ mercaptoacetami-do/ethylenediamine: a potential replacement for 1–131 iodohippurate. J Nucl Med 1981; 22: 258–263.

    PubMed  CAS  Google Scholar 

  42. Fritzberg AR, Kuni CC, Klingensmith WC, Stevens J, Whitney WP. Synthesis and biological evaluation of Tc-99m N, N, bis/mercaptoacetyl/-2, 3-diaminopropanoate: a potential replacement for I-131 o-iodohippur at e. J Nucl Med 1982; 23: 592–598.

    PubMed  CAS  Google Scholar 

  43. Medical Products 1976/7 (Catalogue). The Radiochemical Centre Amersham: 42–43.

    Google Scholar 

  44. Caro RA, Ciscato VA, Radicella R. Kinetics of the phagocytosis of radiogold colloids by the reticuloendothelial system in the rat. Int J Appl Radiat Isotopes 1970; 21: 405–8.

    Article  CAS  Google Scholar 

  45. Spevacek V, Vesely P, Cifka J. Cromatographic determination of the radiochemical purity of colloidal radiogold Au-198 Nucl Res Inst Rez, Report, 1968, 96 pp; see: Analytical Control of Radiopharmaceuticals. Proc. Panel, Vienna 1969. I.A.E.A., Vienna 1970; 171–175.

    Google Scholar 

  46. Davis MA, Jones AG, Trindade H. A rapid and accurate method for sizing radiocolloids. J Nucl Med 1974; 15: 923–928.

    PubMed  CAS  Google Scholar 

  47. Pedersen B, Kristensen K. Evaluation of methods for sizing of colloidal radiopharmaceuticals. Eur J Nucl Med 1981; 6: 521–526.

    PubMed  CAS  Google Scholar 

  48. Krogsgaard OW. Technetium-99m-Sulfur Colloid. Eur J Nucl Med 1976; 1: 31–35.

    PubMed  CAS  Google Scholar 

  49. Cifka J. Methods for the quality control of macroaggregates and colloids labelled with technetium-99m or indium-113m. Part of a joint coordinated research programme on radiopharmaceuticals. Final Report. I.A.E.A. Research contract IAEA-R-1021. 1975, 48 pp.

    Google Scholar 

  50. Frier M, Griffiths P, Ramsey A. The physical and chemical characteristics of sulphur colloids. Eur J Nucl Med 1981; 6: 255–260.

    PubMed  CAS  Google Scholar 

  51. Cifka J, Rajman I, Cabalfin E, Cifkova I. The activity and particle size distribution in sulphur colloid S-Tc-99m of various origin. 3rd European Congress Nucl Med, Karlovy Vary, May 1979.

    Google Scholar 

  52. Cifka J, Vesely P. Non-pertechnetate radiochemical impurity in sulphur colloid labelled with Tc-99m. In: Radiopharmaceuticals and labelled compounds. Proc Symp Copenhagen, March 1973. Vienna, I.A.E.A., 1973; Vol. 1: 53–62.

    Google Scholar 

  53. Technetium Tc-99m Sulfur Colloid Injection. The Pharmacopoeia of the United States of America, Xth Rev 1975; 489.

    Google Scholar 

  54. Morcellet JL, Rousset C, Le Mignant A. Sulfure d’antimoine et de technetium, agent scintigraphi que de la rate et du foie. J Biol Med Nucl 1972; 7: 33–39.

    CAS  Google Scholar 

  55. Khentigan A, Garrett M, Lum D, Winchell HS. Effects of prior administration of Sn/II/ complexes on in vivo distribution of Tc-99m pertechnetate. J Nucl Med 1976; 17: 380–4.

    PubMed  CAS  Google Scholar 

  56. Holt JT, Spitalnik SL, Wilson G. Inhibition of chromium-51 RBC labelling by stannous pyrophosphate. J Nucl Med 1982; 23: 934–935.

    PubMed  CAS  Google Scholar 

  57. Srivastava SC, Meinken G, Richards P. The chemistry of Tc-99m labelling kits. J Labell Comp Radiopharm 1977; 13: 158.

    CAS  Google Scholar 

  58. Fonda U, Pedersen B. Tc-99m Diethy1-HIDA. A contribution to the study of its structure. Eur J Nucl Med 1978; 3: 87–89.

    Article  PubMed  CAS  Google Scholar 

  59. Angelis B, Cifka J, Cifkova I. The preparation of liver diagnostic containing Tc-99m and its characteristic. Radioisotopy 1981; 22: 633–648.

    CAS  Google Scholar 

  60. Kronrad L, Hradilek P. Brousil J, Svihovcova P. Kits for preparation of radiopharmaceuticals labelled with iodine isotopes. 3rd European Congress Nucl Med, Karlovy Vary, May 1979.

    Google Scholar 

  61. Hradilek P, Kronrad L, Kopicka K. Method of preparing radioactive iodinated derivatives of hippuric acid. Czechoslovak Pat Docum 188692/B/, July 15, 1981.

    Google Scholar 

  62. Hinkle GH, Basmadjian GP, Kirschner AS, Ice RD. Kit preparation of radioiodinated o-iodohippuran. J Pharm Sci 1981; 70: 312–316.

    Article  PubMed  CAS  Google Scholar 

  63. Jeyasingh K, Jewkes RF. Simplified kit preparation and use of 1–123 hippuran. In: Proc. 19th Internal Annual Meeting Geselschaft fuer Nuklearmedizin, Bern 1981. 1982; 314–317.

    Google Scholar 

  64. Hawking L, Elliot A, Shields R, et al. A rapid quantitative method for the preparation of 1–123 iodohippuric acid. Eur J Nucl Med 1982; 7: 58–61.

    Google Scholar 

  65. Boyd RE. Mo1ybdenum-99: Technetium-99m Generator. Radiochim Acta 1982; 30: 123–145.

    CAS  Google Scholar 

  66. Molter M. The current status of Tc-99m generators. Nucl Med 1981; 20: 7–10.

    Google Scholar 

  67. Technetium-99m. Generators, Chemistry and Preparation of Radiopharmaceuticals. Eckelman W.C., Coursey B.M., eds. Special Issue. Int J Appl Radiat Isotopes 1982; 33: No 10.

    Google Scholar 

  68. Hesselwood SR. Quality control procedures for Tc-99m complexes. Nucl Med 1981; 20: 3–6.

    Google Scholar 

  69. Cifka J, Rokos A. The silicium content in eluates from indium-113m In generators. Ceskoslov farm. 1979; 28: 399–403.

    CAS  Google Scholar 

  70. Cifka J, Rokos A, Cifkova I. The silicium content in the eluates from In-113m generators and its effect on radiopharmaceuticals. 3rd European Congress Nucl Med, Karlovy Vary, May 1979.

    Google Scholar 

Download references

Authors
  1. Jiri Cifka
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Isotope-Pharmacy, The National Board of Health, Copenhagen, Denmark

    Knud Kristensen  & Elisabeth Nørbygaard  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Martinus Nijhoff Publishers, Boston

About this chapter

Cite this chapter

Cifka, J. (1984). Physical/Chemical Description. In: Kristensen, K., Nørbygaard, E. (eds) Safety and efficacy of radiopharmaceuticals. Developments in Nuclear Medicine, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-6753-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-6753-3_3

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-6755-7

  • Online ISBN: 978-94-009-6753-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation